Form D · Other Health Care
Erbi Biosystems, Inc.
Woburn, MA · CIK 0001753263
Offering snapshot reported Oct 26, 2020 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 2, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2020 | Initial | $2,000,000 | No comparison | 4 | SEC filing |
| Sep 18, 2018 | Initial | $475,196 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-378810
Source: Form D, filed Oct 26, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Chiu | Director, Executive |
| Mark Ehrman | Director |
| Harry Lee | Director, Executive |
| Kevin Lee | Director, Executive |
| Philip Lessard | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
325 New Boston St. Unit 6
Woburn, MA, 01801
Woburn, MA, 01801